Northside Hospital Inc.- GCS/Athens is a clinical research site located in Athens, Georgia, United States 30606.
Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Northside Hospital Inc.- GCS/Athens has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Georgia · View every site in Athens
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Northside Hospital Inc.- GCS/Athens has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northside Hospital Inc.- GCS/Athens has 4 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Breast Neoplasms.
Northside Hospital Inc.- GCS/Athens has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.